Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/22/2025

Ehlers-Danlos Syndrome Diagnosis and Management

Diagnosis

  • Genetic testing is essential for definitive diagnosis, particularly identifying COL3A1 variants in vascular EDS, which is the most life-threatening subtype 1, 2
  • Confirm diagnosis of Vascular EDS (Type IV) through COL3A1 genetic testing 1, 2
  • Perform baseline imaging (MRI or CT) from head to pelvis to evaluate the entire aorta and arterial branches in Vascular EDS patients 1, 3, 4

Treatment of Vascular EDS

  • Implement annual surveillance imaging of dilated or dissected segments, with imaging every 2 years when initial studies are normal 1, 3, 4
  • Celiprolol (beta-blocker with vasodilatory properties) is recommended to reduce vascular morbidity, though it lacks FDA approval in the US 1, 2, 3, 4
  • Maintain optimal blood pressure control 2
  • ARBs have no proven benefit in vascular EDS 3, 4
  • Avoid invasive diagnostic procedures due to risk of fatal complications—use non-invasive imaging exclusively 1, 2
  • Surgical intervention is indicated only for rapid arterial aneurysm growth or acute dissection, as no diameter thresholds exist for prophylactic surgery 1, 3, 4

Treatment of Hypermobile EDS

  • Physical therapy with low-resistance exercise to increase muscle tone and improve joint stability is the cornerstone of treatment, combined with myofascial release techniques 5
  • Perform baseline echocardiogram to evaluate for aortic root dilation 5
  • Treat prominent GI symptoms based on specific manifestations and abnormal function test results 1, 5
  • Special diets (gastroparesis diet, elimination diets) may be considered with mandatory nutritional counseling to prevent restrictive eating 1, 5
  • For POTS, increase fluid and salt intake, implement exercise training, and use compression garments as first-line treatment 1, 5
  • When MCAS is suspected, treat with histamine receptor antagonists and/or mast cell stabilizers 5
  • Implement brain-gut behavioral therapies due to increased rates of anxiety and psychological distress in patients with hypermobility 1, 2

Multidisciplinary Team Approach

  • All EDS subtypes require regular follow-up with a multidisciplinary team including medical geneticists, cardiologists, gastroenterologists, physical medicine specialists, and pain management specialists 1, 2, 5

Critical Pitfalls to Avoid

  • Never use invasive diagnostic procedures in vascular EDS patients 1, 2
  • Never prescribe opioids for chronic pain management, especially with GI manifestations 2, 5
  • Recognize that vessels may rupture or dissect in vascular EDS even without significant dilation 1, 3, 4